1-5 of 5
Shu Chen
Close
Sort by
Journal Articles

Selinexor in Combination with Salvage Regimen for Refractory Peripheral T-Cell Lymphoma (PTCL) Patients

Li Wang, Mingci CAI, Yaohui Huang, Pengpeng Xu, Shu Chen, Weili Zhao
Journal: Blood
Blood (2023) 142 (Supplement 1): 6211.
https://doi.org/10.1182/blood-2023-183040
Published: 2023
Journal Articles

Selinexor in Combination with Salvage Regimen for Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients with TP53 Alterations

Li Wang, Ying Fang, Muchen Zhang, Jie Xiong, Pengpeng Xu, Shu Chen, Weili Zhao
Journal: Blood
Blood (2023) 142 (Supplement 1): 1745.
https://doi.org/10.1182/blood-2023-182674
Published: 2023
Journal Articles

Oral Realgar- Indigo Naturalis Formula Versus Intravenous Arsenic Trioxide for Non-High-Risk Patients with Acute Promyelocytic Leukemia: Interim Results of a Multicenter Randomized Controlled Trial APL16

Huaiyu Wang, Shu Chen, Xiaojuan Zhang, Xinhua Lu, Sha Gong, David Wald, Haitao Zhang, Jing Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 2014–2015.
https://doi.org/10.1182/blood-2022-166635
Published: 2022
Journal Articles

Leonurine Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Cheng Chen, Lin He, Xi Wang, Zichen Ye, Rong Xiao, Hong Zheng, Shu Chen, Hui Li, Xi Yang, Xuemei Wang, Yu Wang, Xuemei Ye, Xiaobing Huang, Jingying Dai
Journal: Blood
Blood (2022) 140 (Supplement 1): 12439.
https://doi.org/10.1182/blood-2022-157665
Published: 2022
Journal Articles

A novel apoptosis pathway activated by the carboxyl terminus of p21

Chen Dong, Qing Li, Shu-chen Lyu, Alan M. Krensky, Carol Clayberger
Journal: Blood
Blood (2005) 105 (3): 1187–1194.
https://doi.org/10.1182/blood-2004-06-2188
Published: 2005